Science

We caught up with Gustaf Hemberg, Co-Founder & CEO of Scindo as part of ‘Product | People | Potential’. Scindo is creating a novel biological...

We caught up with Katie Critchlow, CEO of NatureMetrics, as part of ‘Product | People | Potential’. NatureMetrics use next generation sequencing to identify ...

We caught up with Orr Yarkoni, CEO of Colorifix, as part of ‘Product | People | Potential’. Colorifix uses synthetic biology to remove the need...

We caught up with Clarissa Sowemimo-Coker, General Counsel at Oxford Cannabinoid Technologies, and Valentino Parravicini, the Chief Scientific Officer. Oxfor...

We caught up with George Frodsham, CEO of MediSieve, as part of ‘Product | People | Potential’. MediSieve’s goal is to provide doctors with a...

We caught up with Sean Peters, CEO of DryGro, as part of ‘Product | People | Potential’. DryGro is an agriculture technology company working to...

We caught up with Rory Cameron, CEO and Co-Founder of Gendius as part of ‘Product | People | Potential’. Gendius is developing a diabetes pathway...

We caught up with Jolyon Martin, one of the founders of PetMedix, as part of ‘Product | People | Potential’. PetMedix is using the highest...

We caught up with Dr Mark Treherne, Chairman of Talisman Therapeutics as part of ‘Product | People | Potential’. Talisman Therapeutics is committed to revolu...

We caught up with Jack O’Meara, Founder & CEO of Ochre Bio as part of ‘Product | People | Potential’. Ochre Bio develops genomic medicines...

We caught up with Paul Meakin, CEO of Vitamica, as part of ‘Product | People | Potential’. Vitamica is developing a novel diagnostic technology to...

We caught up with Zuzanna Brzosko, CEO of Sixfold Bioscience as part of ‘Product | People | Potential’. Sixfold Bioscience develops safe and effective drug...